Fergus McTaggart

2.0k total citations
33 papers, 1.6k citations indexed

About

Fergus McTaggart is a scholar working on Surgery, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Fergus McTaggart has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 13 papers in Computational Theory and Mathematics and 12 papers in Molecular Biology. Recurrent topics in Fergus McTaggart's work include Lipoproteins and Cardiovascular Health (20 papers), Computational Drug Discovery Methods (13 papers) and Cancer, Lipids, and Metabolism (11 papers). Fergus McTaggart is often cited by papers focused on Lipoproteins and Cardiovascular Health (20 papers), Computational Drug Discovery Methods (13 papers) and Cancer, Lipids, and Metabolism (11 papers). Fergus McTaggart collaborates with scholars based in United Kingdom, United States and France. Fergus McTaggart's co-authors include Robert G. Davidson, Geoffrey A. Holdgate, Peter J.H. Jones, Ali Raza, Anders Olsson, Linda K. Buckett, Alex McCormick, Dennis W. Schneck, M. John Chapman and Walter H.J. Ward and has published in prestigious journals such as Biochemistry, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Fergus McTaggart

33 papers receiving 1.5k citations

Peers

Fergus McTaggart
Amy O. Johnson‐Levonas United States
Diane MacDougall United States
Phillip D. Toth United States
Lorenzo Melani Italy
Teddy Kosoglou United States
Reagan H. Bradford United States
Kevin B. Alton United States
Paul Martin United Kingdom
Margaret E. Brousseau United States
Tatu Miettinen Finland
Amy O. Johnson‐Levonas United States
Fergus McTaggart
Citations per year, relative to Fergus McTaggart Fergus McTaggart (= 1×) peers Amy O. Johnson‐Levonas

Countries citing papers authored by Fergus McTaggart

Since Specialization
Citations

This map shows the geographic impact of Fergus McTaggart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fergus McTaggart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fergus McTaggart more than expected).

Fields of papers citing papers by Fergus McTaggart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fergus McTaggart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fergus McTaggart. The network helps show where Fergus McTaggart may publish in the future.

Co-authorship network of co-authors of Fergus McTaggart

This figure shows the co-authorship network connecting the top 25 collaborators of Fergus McTaggart. A scholar is included among the top collaborators of Fergus McTaggart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fergus McTaggart. Fergus McTaggart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roxburgh, Campbell S.D., Fergus McTaggart, M Balsitis, & R. H. Diament. (2012). Impact of the bowel‐screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran. Colorectal Disease. 15(1). 34–41. 11 indexed citations
2.
McTaggart, Fergus & Peter J.H. Jones. (2008). Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit. Cardiovascular Drugs and Therapy. 22(4). 321–338. 132 indexed citations
3.
Asztalos, Bela F., Florence Le Maulf, Evan A. Stein, et al.. (2007). Comparison of the Effects of High Doses of Rosuvastatin Versus Atorvastatin on the Subpopulations of High-Density Lipoproteins. The American Journal of Cardiology. 99(5). 681–685. 69 indexed citations
4.
Vidt, Donald G., Susan S. Harris, Fergus McTaggart, et al.. (2006). Effect of Short-Term Rosuvastatin Treatment on Estimated Glomerular Filtration Rate. The American Journal of Cardiology. 97(11). 1602–1606. 61 indexed citations
5.
Sidaway, James E., Robert G. Davidson, Fergus McTaggart, et al.. (2004). Inhibitors of 3-Hydroxy-3-Methylglutaryl–CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney Cells. Journal of the American Society of Nephrology. 15(9). 2258–2265. 121 indexed citations
6.
Caslake, Muriel, Grace Stewart, Stephen Day, et al.. (2003). Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia. Atherosclerosis. 171(2). 245–253. 82 indexed citations
7.
McTaggart, Fergus. (2003). Comparative pharmacology of rosuvastatin. Atherosclerosis Supplements. 4(1). 9–14. 117 indexed citations
8.
Chapman, M. John, Muriel Caslake, Chris J. Packard, & Fergus McTaggart. (2003). New dimension of statin action on apoB atherogenicity. Clinical Cardiology. 26(S1). 7–10. 25 indexed citations
9.
Holdgate, Geoffrey A., Walter H.J. Ward, & Fergus McTaggart. (2003). Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin. Biochemical Society Transactions. 31(3). 528–531. 73 indexed citations
10.
Caslake, Muriel, Dorothy Bedford, Grace Stewart, et al.. (2003). 3P-0786 Rosuvastatin: Kinetics of apoB-containing lipoproteins in moderate hypercholesterolemia. Atherosclerosis Supplements. 4(2). 234–234. 2 indexed citations
11.
Olsson, Anders, Fergus McTaggart, & Ali Raza. (2002). Rosuvastatin: A Highly Effective New HMG‐CoA Reductase Inhibitor. Cardiovascular Drug Reviews. 20(4). 303–328. 174 indexed citations
12.
Chapman, M. John & Fergus McTaggart. (2002). Optimizing the pharmacology of statins: characteristics of rosuvastatin. Atherosclerosis Supplements. 2(4). 33–37. 57 indexed citations
13.
14.
Holdgate, Geoffrey A., et al.. (2001). Kinetics of inhibition of HMG-CoA reductase by a new statin, rosuvastatin. Atherosclerosis Supplements. 2(2). 88–88. 8 indexed citations
15.
Nezasa, Ken-ichi, Kazutaka Higaki, Hiroshi Hasegawa, et al.. (2000). Uptake of HMG-CoA reductase inhibitor ZD4522 into hepatocytes and distribution into liver and other tissues of the rat. Atherosclerosis. 151(1). 39–39. 32 indexed citations
16.
Buckett, Linda K., Peter Ballard, Robert G. Davidson, et al.. (2000). Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells. Atherosclerosis. 151(1). 41–41. 53 indexed citations
17.
Brown, George R., David M. Hollinshead, Elaine S. E. Stokes, et al.. (1999). Quinuclidine Inhibitors of 2,3-Oxidosqualene Cyclase-Lanosterol Synthase:  Optimization from Lipid Profiles. Journal of Medicinal Chemistry. 42(7). 1306–1311. 16 indexed citations
18.
Ward, Walter H.J., Geoffrey A. Holdgate, S Freeman, et al.. (1996). Inhibition of squalene synthase in vitro by 3-(biphenyl-4-yl)-quinuclidine. Biochemical Pharmacology. 51(11). 1489–1501. 14 indexed citations
19.
McTaggart, Fergus, George R. Brown, Robert G. Davidson, et al.. (1996). Inhibition of squalene synthase of rat liver by novel 3′ substituted quinuclidines. Biochemical Pharmacology. 51(11). 1477–1487. 35 indexed citations
20.
Buckley, C., et al.. (1996). Oxidized low‐density lipoproteins inhibit endothelium‐dependent relaxations in isolated large and small rabbit coronary arteries. Journal of Autonomic Pharmacology. 16(5). 261–268. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy O. Johnson‐Levonas Breakdown of academic impact, for papers by Diane MacDougall Breakdown of academic impact, for papers by Phillip D. Toth Breakdown of academic impact, for papers by Lorenzo Melani Breakdown of academic impact, for papers by Teddy Kosoglou Breakdown of academic impact, for papers by Reagan H. Bradford Breakdown of academic impact, for papers by Kevin B. Alton Breakdown of academic impact, for papers by Paul Martin Breakdown of academic impact, for papers by Margaret E. Brousseau Breakdown of academic impact, for papers by Tatu Miettinen
Rankless by CCL
2026